je.st
news
Tag: kgaa
Sigma-Aldrich and Merck KGaA, Darmstadt, Germany, Making Progress Toward Completion of Planned Acquisition
2015-09-30 12:31:09| Industrial Newsroom - All News for Today
ST. LOUIS Sigma-Aldrich Corporation (NASDAQ: SIAL) announced today it is making progress toward closing the planned acquisition of the Company by Merck KGaA, Darmstadt, Germany. The closing is now expected within the next two months. On August 11, 2015, Sigma-Aldrich and Merck announced they had obtained all...
Tags: making
germany
progress
planned
Merck KGaA, Darmstadt, Germany, And Pfizer Announce FDA Orphan Drug Designation For Investigational Immunotherapy Avelumab In Merkel Cell Carcinoma
2015-09-30 08:25:02| drugdiscoveryonline News Articles
Merck KGaA, Darmstadt, Germany, and Pfizer recently announced that the US Food and Drug Administration (FDA) has granted orphan drug designation for the investigational cancer immunotherapy avelumab* for the treatment of Merkel cell carcinoma (MCC), a rare and aggressive type of skin cancer
Tags: germany
cell
drug
announce
Merck KGaA Rating Lowered to Sell at Societe Generale
2015-09-28 01:56:21| Biotech - Topix.net
Separately, Nomura downgraded Merck KGaA from a "buy" rating to a "neutral" rating in a research report on Friday, January 4th.
Tags: rating
sell
generale
lowered
UPDATE 2-Merck KGaA sees AZ deal and forex countering weak drug sales
2015-05-20 02:15:32| Biotech - Topix.net
The recent takeover of high-tech chemicals maker AZ Electronic Materials and a strong U.S. dollar will help Merck KGaA to counter a drop in revenue from its best-selling drug this year, it said on Tuesday. However, shares in the company dropped 1.7 percent, the biggest decline on Germany's blue-chip DAX index, as analysts' expressed concern at a 15.9 percent fall in currency-adjusted sales of multiple sclerosis treatment Rebif -- its biggest medicine -- in the first quarter of this year.
RPT-Merck KGaA says to overcome EU concerns on Sigma-Aldrich deal
2015-05-19 18:14:38| Chemicals - Topix.net
May 19 Merck KGaA said European Union antitrust regulators had concerns "of a limited nature" about its planned takeover of laboratory supplies maker Sigma-Aldrich but it expects to wrap up the deal around mid-year. The group expects to address the EU's concerns and close the transaction not long after June 30 at the latest, Merck's finance chief Marcus Kuhnert told journalists in a conference call on Tuesday.
Tags: deal
concerns
overcome
kgaa